High-dose therapy with autologous stem cell transplantation in first response in mantle cell lymphoma

Haematologica

Volumn 90, Issue 11, 2005, Pages 1580-1582

  Vigouroux, Stéphane ^a   Gaillard, Fanny ^a   Moreau, Philippe ^a   Harousseau, Jean Luc ^a   Milpied, Noël ^a  

^a HÔTEL DIEU   (France)

Author keywords

Autologous stem cell transplantation; High dose therapy; Mantle cell lymphoma

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; MALE; MANTLE CELL LYMPHOMA; PHYSICAL EXAMINATION; THORAX RADIOGRAPHY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; PREDNISONE; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; VINCRISTINE;

EID: 27844469691     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Milpied N, Gafflard F, Moreau P, Mahe B, Souchet J, Rapp MJ, et al. High-dose therapy with stem cell transplantation for mande cell lymphoma: results and prognostic factors, a single center experience. Bone Marrow Transplant 1998;22:645-50.
2. Deconinck E, Foussard C, Milpied N, Bertrand P, Michenet P, Cornillet-LeFebvre P, et al. High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS. Blood 2005;105:3817-23.
3. Oinonen R, Franssila K, Teerenhovi L, Lappalainen K, Elonen E. Mande cell lymphoma: clinical features, treatment and prognosis of 94 patients. Eur J Cancer 1998;34:329-36.
4. Gianni AM, Magni M, Martelli M, Di Nicola M, Carlo-Stella C, Pilotti S, et al. Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen). Blood 2003;102:749-55.
5. Howard OM, Gribben JG, Neuberg DS, Grossbard M, Poor C, Janicek MJ, et al. Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival. J Clin Oncol 2002;20:1288-94.
6. Lenz G, Dreyling M, Hoster E, Wormann B, Duhrsen U, Metzner B, et al. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). J Clin Oncol 2005;23:1984-92.
7. Dreyling M, Lenz G, Hoster E, Van Hoof A, Gisselbrecht C, Schmits R, et al. Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mande cell lymphoma - results of a prospective randomized trial of the European MCL network. Blood 2005;105:2677-84.